Kitas GD - Search Results

1

Disease assessment and management of the vasculitides.

Luqmani RA, Exley AR, Kitas GD, Bacon PA. Luqmani RA, et al. Among authors: kitas gd. Baillieres Clin Rheumatol. 1997 May;11(2):423-46. doi: 10.1016/s0950-3579(97)80052-0. Baillieres Clin Rheumatol. 1997. PMID: 9220084 Review.

2

Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.

Kitas GD, Farr M, Waterhouse L, Bacon PA. Kitas GD, et al. Scand J Rheumatol. 1992;21(5):220-5. doi: 10.3109/03009749209099228. Scand J Rheumatol. 1992. PMID: 1359635

3

Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis.

Farr M, Kitas GD, Tunn EJ, Bacon PA. Farr M, et al. Among authors: kitas gd. Br J Rheumatol. 1991 Dec;30(6):413-7. doi: 10.1093/rheumatology/30.6.413. Br J Rheumatol. 1991. PMID: 1684124

4

Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study.

Farr M, Kitas GD, Waterhouse L, Jubb R, Felix-Davies D, Bacon PA. Farr M, et al. Among authors: kitas gd. Br J Rheumatol. 1990 Feb;29(1):46-9. doi: 10.1093/rheumatology/29.1.46. Br J Rheumatol. 1990. PMID: 1968355 Clinical Trial.

5

Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.

Farr M, Kitas G, Bacon PA. Farr M, et al. Clin Rheumatol. 1988 Jun;7(2):242-8. doi: 10.1007/BF02204462. Clin Rheumatol. 1988. PMID: 2901303

6

Treatment of psoriatic arthritis with sulphasalazine: a one year open study.

Farr M, Kitas GD, Waterhouse L, Jubb R, Felix-Davies D, Bacon PA. Farr M, et al. Among authors: kitas gd. Clin Rheumatol. 1988 Sep;7(3):372-7. doi: 10.1007/BF02239195. Clin Rheumatol. 1988. PMID: 2906579 Clinical Trial.

7

The T cell system in rheumatoid arthritis: activated or defective?

Kitas GD, Salmon M, Allan IM, Bacon PA. Kitas GD, et al. Scand J Rheumatol Suppl. 1988;76:161-73. doi: 10.3109/03009748809102966. Scand J Rheumatol Suppl. 1988. PMID: 3075073 Review.

8

A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.

Farr M, Waterhouse L, Johnson AE, Kitas GD, Jubb RW, Bacon PA. Farr M, et al. Among authors: kitas gd. Clin Rheumatol. 1995 Sep;14(5):531-6. doi: 10.1007/BF02208150. Clin Rheumatol. 1995. PMID: 8549091 Clinical Trial. No abstract available.

9

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.

Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, Adu D. Exley AR, et al. Among authors: kitas gd. Arthritis Rheum. 1997 Feb;40(2):371-80. doi: 10.1002/art.1780400222. Arthritis Rheum. 1997. PMID: 9041949

10

Damage occurs early in systemic vasculitis and is an index of outcome.

Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA, Savage CO, Bacon PA. Exley AR, et al. Among authors: kitas gd. QJM. 1997 Jun;90(6):391-9. doi: 10.1093/qjmed/90.6.391. QJM. 1997. PMID: 9205677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results